hrp0097fc11.4 | GH and IGFs | ESPE2023
Dorrepaal Demi
, Goedegebuure Wesley
, Smagge Lucas
, van der Steen Manouk
, van der Lugt Aad
, Hokken-Koelega Anita
Background: Increased cerebrovascular morbidity and mortality was reported in adults who were treated with growth hormone (GH) during childhood, including those born SGA, compared to the general population. However, previous studies did not have an appropriate control group of untreated SGA adults which was a major limitation.Objective: To assess cerebrovascular abnormalities (aneurysms, previous intracerebral hemorrhage...